找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Noncolorectal, Nonneuroendocrine Liver Metastases; Diagnosis and Curren Isidoro Di Carlo Book 2015 Springer International Publishing Switze

[復制鏈接]
查看: 20020|回復: 61
樓主
發(fā)表于 2025-3-21 16:48:05 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Noncolorectal, Nonneuroendocrine Liver Metastases
副標題Diagnosis and Curren
編輯Isidoro Di Carlo
視頻videohttp://file.papertrans.cn/668/667184/667184.mp4
概述First monograph to focus specifically on noncolorectal non neuroendocrine (NCRNNE) liver metastases.Offers extensive guidance on treatment of metastases from different primary malignancies.Serves as a
圖書封面Titlebook: Noncolorectal, Nonneuroendocrine Liver Metastases; Diagnosis and Curren Isidoro Di Carlo Book 2015 Springer International Publishing Switze
描述This book offers a complete overview on non colorectal non neuroendocrine (NCRNNE) liver metastases and describes in detail the currently available therapies. Each chapter focuses on the treatment of metastases from a particular primary malignancy and also provides valuable information on incidence, natural history and diagnosis. NCRNNE liver metastases are rare entities compared with colorectal and neuroendocrine metastases, for which the treatments are well codified. While more publications have appeared on the topic in recent years, an in-depth study has to date been lacking. Furthermore, most published series are insufficiently comparable as they comprise patients with NCRNNE hepatic metastases from a variety of primary malignancies and consequently overlook differences in tumor behavior, frequency of isolated hepatic metastases, response to neoadjuvant or adjuvant therapy and interval between diagnosis of the primary tumor and the liver metastases. This book, with its more specific approach, will serve not only as an up-to-date guide to diagnosis and treatment but also as a reference on which to base future studies.
出版日期Book 2015
關鍵詞Extra hepatic tumors; Liver metastases resection; Non colorectal metastases; Non neuroendocrine metasta
版次1
doihttps://doi.org/10.1007/978-3-319-09293-5
isbn_softcover978-3-319-35773-7
isbn_ebook978-3-319-09293-5
copyrightSpringer International Publishing Switzerland 2015
The information of publication is updating

書目名稱Noncolorectal, Nonneuroendocrine Liver Metastases影響因子(影響力)




書目名稱Noncolorectal, Nonneuroendocrine Liver Metastases影響因子(影響力)學科排名




書目名稱Noncolorectal, Nonneuroendocrine Liver Metastases網絡公開度




書目名稱Noncolorectal, Nonneuroendocrine Liver Metastases網絡公開度學科排名




書目名稱Noncolorectal, Nonneuroendocrine Liver Metastases被引頻次




書目名稱Noncolorectal, Nonneuroendocrine Liver Metastases被引頻次學科排名




書目名稱Noncolorectal, Nonneuroendocrine Liver Metastases年度引用




書目名稱Noncolorectal, Nonneuroendocrine Liver Metastases年度引用學科排名




書目名稱Noncolorectal, Nonneuroendocrine Liver Metastases讀者反饋




書目名稱Noncolorectal, Nonneuroendocrine Liver Metastases讀者反饋學科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權限
沙發(fā)
發(fā)表于 2025-3-21 22:19:11 | 只看該作者
板凳
發(fā)表于 2025-3-22 02:20:34 | 只看該作者
Liver Metastases from Prostate Cancer,t of LM from prostate cancer should be individualized based on the patient’s clinical course, extent of disease, and symptoms. Multimodality therapy is often employed in the management of metastatic disease in the liver. The purpose of this chapter is to present the incidence, natural history, diagnosis, and treatment of LM from prostate cancer.
地板
發(fā)表于 2025-3-22 07:34:44 | 只看該作者
5#
發(fā)表于 2025-3-22 12:22:12 | 只看該作者
Book 2015erapies. Each chapter focuses on the treatment of metastases from a particular primary malignancy and also provides valuable information on incidence, natural history and diagnosis. NCRNNE liver metastases are rare entities compared with colorectal and neuroendocrine metastases, for which the treatm
6#
發(fā)表于 2025-3-22 14:14:49 | 只看該作者
7#
發(fā)表于 2025-3-22 17:06:19 | 只看該作者
Liver Metastases in Thyroid Cancer,or curative or palliative treatment. Without doubts, in the following decade the ongoing development of liver-directed therapies will benefit the outcome of patients with liver metastases from any organ and thus also for patients with liver metastases in thyroid carcinoma.
8#
發(fā)表于 2025-3-23 00:04:42 | 只看該作者
Liver Metastases from Ureteral and Bladder Cancer, patients with a solitary or only several liver lesions after achieving a major clinical response to chemotherapy may receive benefits from liver-directed therapies, including radiofrequency thermal ablation.
9#
發(fā)表于 2025-3-23 03:27:45 | 只看該作者
10#
發(fā)表于 2025-3-23 06:14:48 | 只看該作者
 關于派博傳思  派博傳思旗下網站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網 吾愛論文網 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經驗總結 SCIENCEGARD IMPACTFACTOR 派博系數 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網安備110108008328) GMT+8, 2025-10-15 11:30
Copyright © 2001-2015 派博傳思   京公網安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
博野县| 雷波县| 永定县| 涟水县| 武邑县| 县级市| 时尚| 通河县| 冕宁县| 林州市| 大安市| 盐津县| 乡城县| 长武县| 台前县| 旬邑县| 云梦县| 靖远县| 潢川县| 潜江市| 惠州市| 甘孜县| 句容市| 西充县| 湄潭县| 昌乐县| 金华市| 化德县| 龙口市| 平乡县| 巴楚县| 定安县| 屏山县| 霍山县| 永德县| 高邮市| 商河县| 长寿区| 高台县| 如皋市| 修武县|